Targeting inflammation to prevent severe acute pancreatitis: NSAIDs are not the holy grail

Dig Liver Dis. 2024 Jun;56(6):1021-1022. doi: 10.1016/j.dld.2024.02.015. Epub 2024 Mar 11.

Authors

Gabriele Capurso¹, Alberto Malesci²

Affiliations

¹ Pancreatobiliary Endoscopy and Endosonography Division, IRCCS San Raffaele Scientific Institute, Milan, Italy; Vita-Salute San Raffaele University, Milan, Italy. Electronic address: capurso.gabriele@hsr.it.
² Division of Gastroenterology and Gastrointestinal Endoscopy, IRCCS San Raffaele Scientific Institute, Milan, Italy; Vita-Salute San Raffaele University, Milan, Italy.

PMID: 38462428
DOI: 10.1016/j.dld.2024.02.015

No abstract available

Publication types

Editorial

MeSH terms

Acute Disease
Anti-Inflammatory Agents, Non-Steroidal* / adverse effects
Anti-Inflammatory Agents, Non-Steroidal* / therapeutic use
Humans
Inflammation
Pancreatitis* / chemically induced
Pancreatitis* / prevention & control

Substances

Anti-Inflammatory Agents, Non-Steroidal